Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first ...
Medical Health News,
Introduction There are currently five approved tyrosine kinase inhibitors (TKIs) for the treatment of chronic phase chronic…
Introduction There are currently five approved tyrosine kinase inhibitors (TKIs) for the treatment of chronic phase chronic…
By Yazad Irani, Post-Doctoral Researcher, South Australian Health
This article is part of the series This is research, where we ask academics to share and discuss open access articles that…
medwireNews: Patients with chronic myeloid leukemia (CML) who successfully discontinue imatinib treatment have a higher…